Skip to search formSkip to main contentSkip to account menu

Lanoxicaps

Known as: GlaxoSmithKline Brand 2 of Digoxin 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1994
Review
1994
This 72‐year‐old white woman with diabetes mellitus (Type II) and ischemic cardiomyopathy was referred for evaluation on the day… 
1991
1991
The bioavailability of digoxin in solution (Lanoxicaps, 90–100 percent) is superior to that of Lanoxin tablets (60–80 percent) in… 
1986
1986
The oral absorption of digoxin in tablet form has been reported to be reduced after cancer chemotherapy and radiation therapy… 
1983
1981
1981
Ten healthy subjects took each of 6 different solutions of 0.5 mg digoxin in a study of the effect of different solvents on… 
1978
1978
Summary(1) The mean cumulative urinary digoxin excretion over 8 days was compared in 8 healthy volunteers after single doses of… 
1977
1977
1 Twice daily administration of 0.25 mg digoxin tablets (Lanoxin) or of 0.2 mg digoxin in solution in soft gelatin capsules…